Skip to content
MedsAcross

Manufacturer

Daiichi Sankyo

Pharmaceutical manufacturer based in Japan
Japan
Products listed
8
Molecules
5
Therapy areas
2

Daiichi Sankyo is a pharmaceutical manufacturer based in Japan. MedsAcross lists 8 of its products across 5 molecules, each with registers, packs and availability for export supply to licensed buyers.

Country
Japan
Indian manufacturer
No
Also listed as
Daiichi Sankyo Inc.
US FDA labeler
YesSource: openFDA NDC directory

Source from this manufacturer

We supply Daiichi Sankyo products through licensed channels, with the documents your regulator needs.

Oncology

5 presentations

Oncology overview
MedicineActive ingredientRegisterAvailability
Datroway 100 mg/5 mL powder for injectionIntravenous Cold chainDatopotamab deruxtecanUS FDAAvailable on request
Enhertu 100 mg/5 mL powder for injectionIntravenous Cold chainTrastuzumab deruxtecanUS FDAAvailable on request
Turalio 125 mg capsuleOralPexidartinibUS FDAAvailable on request
Vanflyta 17.7 mg tabletOralQuizartinibUS FDAAvailable on request
Vanflyta 26.5 mg tabletOralQuizartinibUS FDAAvailable on request

Haematology

3 presentations

Haematology overview
MedicineActive ingredientRegisterAvailability
Savaysa 15 mg tabletOralEdoxabanUS FDAAvailable on request
Savaysa 30 mg tabletOralEdoxabanUS FDAAvailable on request
Savaysa 60 mg tabletOralEdoxabanUS FDAAvailable on request

Molecules made

Manufacturer facts come from public registers and are shown with their source. Listing does not mean the manufacturer endorses MedsAcross.

Source from Daiichi Sankyo

Send a request for any of these products. We confirm the licensed source, documents and lead time.